医中誌リンクサービス


文献リスト

1) Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. NEJM. 1996; 334: 693-9
医中誌リンクサービス
2) Yoo HY, Patt CH, Geschwind JF, et al. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1987 and 2001: 5-year survival has improved significantly with time. J Clin Oncol. 2003; 21: 4329-35
PubMed CrossRef
医中誌リンクサービス
3) Marsh JW, Dvorchik I. Liver organ allocation for hepatocellular carcinoma: are we sure? Liver Transpl. 2003; 9: 693-6
PubMed CrossRef
医中誌リンクサービス
4) Roayaie S, Frischer JS, Emre SH, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg. 2002; 235: 533-9
PubMed CrossRef
医中誌リンクサービス
5) Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001; 33: 1394-403
PubMed CrossRef
医中誌リンクサービス
6) Onaca N, Davis GL, Goldstein RM, et al. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the international registry of hepatic tumors in liver transplantation. Liver Transpl. 2007; 13: 391-9
PubMed CrossRef
医中誌リンクサービス
7) Broelsh CE, Frilling A, Malago M. Should we expand the criteria for liver transplantation for hepatocellular carcinoma: yes, of course! J Hepatol. 2005; 43: 569-73
PubMed CrossRef
医中誌リンクサービス
8) Hiatt JR, Carmody IC, Busutiil RW. Should we expand the criteria for liver transplantation for hepatocellular carcinoma? no never. J Hepatol. 2005; 43: 573-7
PubMed CrossRef
医中誌リンクサービス
9) Decaens T, Roudot-Thoraval F, Hadni-Bresson S, et al. Impact of UCSF patients listed for HCC with a short waiting time. Liver Transpl. 2006; 12: 1761-9
PubMed CrossRef
医中誌リンクサービス
10) Duffy JP, Vardanian A, Benjamin E, et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg. 2007; 246: 502-11
PubMed CrossRef
医中誌リンクサービス
11) Kaihara S, Kiuchi T, Ueda M, et al. Living-donor liver transplantation for hepatocellular carcinoma. Transplantation. 2003; 75: S37-40
PubMed
医中誌リンクサービス
12) Todo S, Furukawa H. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg. 2004; 239: 451-61
医中誌リンクサービス
13) Lesurtel M, Mullhaupt B, Pestalozzi BC, et al. Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis. Am J Transpl. 2006; 6: 2644-50
医中誌リンクサービス
14) Lu DS, Yu NC, Raman SS, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology. 2005; 41: 1130-7
PubMed CrossRef
医中誌リンクサービス
15) Mazzaferro V, Battiston C, Perrone S, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg. 2004; 240: 900-9
PubMed CrossRef
医中誌リンクサービス
16) Yao FY, Hirose R, LaBerge JM, et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl. 2005; 11: 1505-14
PubMed CrossRef
医中誌リンクサービス
17) Yao FY, Kinkhabwala M, LeBerge JM, et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant. 2005; 5: 795-804
PubMed CrossRef
医中誌リンクサービス
18) Freedman RB, Mithoefer A, Ruthazer R, et al. Optimizing staging for hepatocellular carcinoma before liver transplantation: a retrospective analysis of the UNOS /OPTN database. Liver Transpl. 2006; 12: 1504-11
PubMed CrossRef
医中誌リンクサービス
19) Zimmerman MA, Trotter JF, Wachs M, et al. Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience. Transpl Int. 2007; 20: 747-53
PubMed CrossRef
医中誌リンクサービス
20) Pawlik TM, Gleisner AL, Anders RA, et al. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implication for transplant eligibility. Ann Surg. 2007; 245: 435-42
PubMed CrossRef
医中誌リンクサービス
21) Marubashi S, Dono K, Sugita Y, et al. Alpha-fetoprotein mRNA detection in peipheral blood for prediction of hepatocellular carcinoma recrrence after liver transplantation. Transplant Proc. 2006; 38: 3640-2
PubMed CrossRef
医中誌リンクサービス
22) Furukawa H, Shimamura T, Suzuki T, et al. Living-donor liver transplantation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2006; 13: 393-7
医学中央雑誌刊行会  PubMed CrossRef
医中誌リンクサービス


NPO医学中央雑誌刊行会
https://www.jamas.or.jp/
info@jamas.or.jp